首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >Pituitary adenoma and apoplexy during GnRH agonist treatment for IVF-case report
【24h】

Pituitary adenoma and apoplexy during GnRH agonist treatment for IVF-case report

机译:垂体腺瘤和中风在GNRH激动剂治疗期间IVF案例报告

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In vitro fertilization is commonly used for treating infertility. One stage of this process is controlled hyperstimulation of the ovaries, achieved by administering gonadotropins. There are several stimulation protocols utilized that increase the number of ovarian follicles during IVF. The most common protocol employs desensitization - the inhibition of follicle-stimulating hormone and luteinizing hormone secretion by the pituitary gland. This is achieved by administering a gonadotropin-releasing hormone (GnRH) analog that is agonistic for the GnRH receptor. However the use of a this drug during therapy carries a risk of complications. This case report deals with a rare case of a woman who underwent pituitary tumor growth as a result of the treatment of GnRH analog.
机译:体外施肥通常用于治疗不孕症。 通过施用促性腺激素来控制该过程的一个阶段是对卵巢的过度刺激。 有几种刺激方案利用,增加IVF期间卵巢卵泡的数量。 最常见的方案使用脱敏 - 抑制卵泡刺激激素和垂体腺体的叶氏化素分泌。 这是通过施用促进的促进促性腺素的释放激素(GnRH)类似物的促进的GnRH受体来实现。 然而,在治疗过程中使用这种药物具有并发症的风险。 本案例报告了罕见的是一例是由于治疗GNRH类似物而接受垂体肿瘤生长的女性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号